Sergey Yurasov
Board Member
Black Diamond Therapeutics, Inc. (BDTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sergey Yurasov
Sergey Yurasov is recorded as Board Member at Black Diamond Therapeutics, Inc. (BDTX). The proxy statement of Black Diamond Therapeutics, Inc. reports total compensation of $1,352,097 for Sergey Yurasov in fiscal 2025, including a base salary of $525,600. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Black Diamond Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark A. Velleca CEO
- Mark A. Velleca, M.D., Ph.D. CEO, Chairman
- Mark Velleca CEO
- Mark Velleca, M.D., Ph.D. CEO, Board Member
- Erika Jones CFO, Chief Accounting Officer, Board Member
- Brent Hatzis-Schoch Board Member
- Elizabeth Buck Board Member
- Kapil Dhingra Board Member
- Melanie Morrison Board Member
- Prakash Raman, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Black Diamond Therapeutics, Inc. (BDTX) | M.D., Ph.D. Chief Medical Officer | $525,600 | $1,352,097 |
| 2024 | Black Diamond Therapeutics, Inc. (BDTX) | M.D., Ph.D. Chief Medical Officer | $507,800 | $1,514,820 |
| 2023 | Black Diamond Therapeutics, Inc. (BDTX) | M.D., Ph.D. Chief Medical Officer | $488,250 | $1,233,684 |
Recent activity
No call appearances or filed executive changes recorded yet.